PLAC4 and β-HCG mRNA levels are not altered in the maternal circulation of pregnancies with trisomy 21 (original) (raw)
First Trimester Biochemical Screening for Trisomy 21: The Role of Free β-hCG and Pregnancy Associated Plasma Protein
Lars Breimer
Annals of Clinical Biochemistry, 1995
View PDFchevron_right
First-Trimester Screening for Trisomy 21 by Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A: Impact of Maternal and Pregnancy Characteristics
Kevin Spencer
Obstetrical & Gynecological Survey, 2008
View PDFchevron_right
First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?
Kevin Spencer
Prenatal Diagnosis, 2008
View PDFchevron_right
First-trimester screening for trisomy 21 with adjustment for biochemical results of previous pregnancies
Argyro Syngelaki
Fetal diagnosis and therapy, 2011
View PDFchevron_right
Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy
Kevin Williams
Annals of Clinical Biochemistry, 2002
View PDFchevron_right
Synergy of Total PLAC4 RNA Concentration and Measurement of the RNA Single-Nucleotide Polymorphism Allelic Ratio for the Noninvasive Prenatal Detection of Trisomy 21
Ranjit Akolekar
Clinical Chemistry, 2010
View PDFchevron_right
Screening for fetal trisomy 21 in gestational weeks 6 and 7
Olav Petersen
Acta Obstetricia et Gynecologica Scandinavica, 2010
View PDFchevron_right
Identification of universal mRNA markers for noninvasive prenatal screening of trisomies
Vittorio Bini
2010
View PDFchevron_right
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Kevin Spencer
Prenatal Diagnosis, 2000
View PDFchevron_right
First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
Sophie Dreux
Ultrasound in Obstetrics & Gynecology, 2012
View PDFchevron_right
Performance characteristics of Elecsys free βhCG and PAPP-A for first trimester trisomy 21 risk assessment in gestational weeks 8+0 to 14+0
Annie Vereecken
LaboratoriumsMedizin, 2016
View PDFchevron_right
First Trimester Biochemical Screening for Trisomy 21
Tim Reynolds
Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, 1995
View PDFchevron_right
Distinctive pattern of first trimester maternal serum biochemical markers in trisomy 22 pregnancies
M. Karkaletsi
Prenatal Diagnosis, 2008
View PDFchevron_right
First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing
Argyro Syngelaki
Fetal Diagnosis and Therapy, 2014
View PDFchevron_right
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free b-hCG and pregnancy-associated plasma protein-A
catalina valencia
2000
View PDFchevron_right
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free hCG and pregnancy-associated plasma protein-A
catalina valencia
Human Reproduction, 2008
View PDFchevron_right
Prospective validation of first-trimester combined screening for trisomy 21
Adolfo Etchegaray
Ultrasound in Obstetrics and Gynecology, 2009
View PDFchevron_right
Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy
Dominique Porquet
Journal of Clinical …, 2004
View PDFchevron_right
Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
Ivilina Pandeva
Ultrasound in Obstetrics and Gynecology, 2008
View PDFchevron_right
Maternal weight correction of maternal serum PAPP-A and free ?-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy
Kevin Spencer
Prenatal Diagnosis, 2003
View PDFchevron_right
First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study
Vicenç Cararach, Elena Casals
Prenatal Diagnosis, 2004
View PDFchevron_right
HCG concentration and receptor gene expression in placental tissue from trisomy 18 and 21
SYLVAIN MEURIS
Molecular Human Reproduction, 2000
View PDFchevron_right
Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies
Kevin Spencer
American Journal of Obstetrics and Gynecology, 2005
View PDFchevron_right
One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies
Kevin Spencer
Ultrasound in Obstetrics and Gynecology, 2002
View PDFchevron_right
Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free ?-hCG or PAPP-A levels?
Kevin Spencer
Prenatal Diagnosis, 2001
View PDFchevron_right
Influence of first trimester biochemistry methodology on detection rate in screening for trisomy 21
Dariusz Borowski
Ginekologia Polska, 2017
View PDFchevron_right
Prospective study evaluating performance of first-trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP-A and free β-hCG
A. Tabor
Ultrasound in Obstetrics & Gynecology, 2012
View PDFchevron_right
Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21
Daljit Sahota
Ultrasound in Obstetrics and Gynecology, 2009
View PDFchevron_right
First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction
Nikos Kametas
Human Reproduction, 2001
View PDFchevron_right
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks
Kevin Spencer
Ultrasound in Obstetrics and Gynecology, 2006
View PDFchevron_right